Trial Profile
Prospective Clinical Study to Observe the Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months Treatment in China
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2023
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 16 Nov 2023 Status changed from active, no longer recruiting to completed.
- 04 Jun 2022 Primary endpoint has been met (Change from baseline Disease Activity Score 28 (DAS28-ESR) at 24 weeks) , according to Results presented at the 23rd Annual Congress of the European League Against Rheumatism
- 04 Jun 2022 Status changed to active, no longer recruiting , according to Results presented at the 23rd Annual Congress of the European League Against Rheumatism